Next Article in Journal
Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease
Previous Article in Journal
Median Arcuate Ligament Syndrome Clinical Presentation, Pathophysiology, and Management: Description of Four Cases
Previous Article in Special Issue
Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine
Due to scheduled maintenance work on our core network, there may be short service disruptions on this website between 16:00 and 16:30 CEST on September 25th.
Review

Clinical Impact of Sarcopenia on Gastrointestinal Tumors

1
Surgery Resident, Braga Hospital, 4710-243 Braga, Portugal
2
Coloproctology Unit, Surgery Department, Braga Hospital, 4710-243 Braga, Portugal
3
School of Medicine, University of Minho, 4710-070 Braga, Portugal
4
PT Government Associate Laboratory, Life and Health Sciences Research Institute (ICVS)/3B’s, 4710-070 Braga/Guimarães, Portugal
*
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2021, 3(1), 51-60; https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3010006
Received: 21 January 2021 / Revised: 26 February 2021 / Accepted: 26 February 2021 / Published: 23 March 2021
Preoperative risk stratification in cancer surgery is important to improve treatment and outcome. Sarcopenia is defined by progressive and generalized loss of skeletal muscle mass and strength and is now getting attention as a poor prognostic factor. The purpose of this review was to explore the impact of sarcopenia on short and long-term outcomes in patients undergoing surgical resection of gastrointestinal tumors. Recent studies suggest that sarcopenia contributes to postoperative complications and overall survival. The relatively simple evaluability, as well as its modifiable nature, provides an intriguing potential for sarcopenia to be included in standard preoperative clinical evaluation. Such evaluations can provide physicians with important information to target high-risk individuals with prophylactic measures and eventually improve surgical outcomes. View Full-Text
Keywords: gastrointestinal tumors; morbimortality; sarcopenia gastrointestinal tumors; morbimortality; sarcopenia
MDPI and ACS Style

Pereira, A.; Pereira, J.C.; Martins, S.F. Clinical Impact of Sarcopenia on Gastrointestinal Tumors. Gastrointest. Disord. 2021, 3, 51-60. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3010006

AMA Style

Pereira A, Pereira JC, Martins SF. Clinical Impact of Sarcopenia on Gastrointestinal Tumors. Gastrointestinal Disorders. 2021; 3(1):51-60. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3010006

Chicago/Turabian Style

Pereira, Ana, Joaquim C. Pereira, and Sandra F. Martins 2021. "Clinical Impact of Sarcopenia on Gastrointestinal Tumors" Gastrointestinal Disorders 3, no. 1: 51-60. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3010006

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop